Related Experiment Videos

Lensectomy-vitrectomy for stage V cicatricial retrolental fibroplasia

Ophthalmic Surgery
|April 1, 1982
PubMed

Insights

Blindness from cicatricial retrolental fibroplasia in infants is rising. Surgical intervention for advanced cicatricial retrolental fibroplasia (RLF) is ineffective, highlighting the need for preventive therapies in high-risk infants.

Area of Science:

  • Ophthalmology
  • Neonatal Care
  • Surgical Innovation

Background:

  • Retrolental fibroplasia (RLF) is a leading cause of blindness in premature infants.
  • Stage V cicatricial RLF represents an advanced, irreversible stage of the disease.
  • Increased survival rates of low birthweight infants contribute to a rising incidence of RLF.

Observation:

  • Ten infants with stage V cicatricial RLF were studied.
  • Surgical interventions including lensectomy-vitrectomies and pars plana vitrectomies were performed on 12 eyes.
  • Seven eyes were not operated, with five showing stage V RLF and two stable at stage II RLF.

Findings:

  • All surgical attempts to reattach retinas failed.
  • The Eifrig-Merritt sign indicated imminent surgical failure.
  • Post-operative complications included vitreous hemorrhages, glaucoma, and phthisis bulbi in some cases.

Implications:

  • Surgical visual rehabilitation is not feasible once cicatricial RLF has formed.
  • Identifying and addressing early perinatal risk factors is crucial for prevention.
  • Preventive therapies targeting high-risk populations are essential to reduce RLF-related blindness.

Related Concept Videos